Please login to the form below

Not currently logged in
Email:
Password:

New Zealand

This page shows the latest New Zealand news and features for those working in and with pharma, biotech and healthcare.

FDA approves GSK’s Priorix vaccine for measles, mumps and rubella

FDA approves GSK’s Priorix vaccine for measles, mumps and rubella

The treatment is currently licensed in more than 100 countries globally, including all European countries, Australia, New Zealand and Canada, with a roll-out of over 800 million doses to date.

Latest news

More from news
Approximately 3 fully matching, plus 70 partially matching documents found.

Latest Intelligence

  • A new era for UK-Japanese scientific research relations A new era for UK-Japanese scientific research relations

    The TPP covers 11 pacific trading nations, including Australia, New Zealand, Canada and Malaysia, valued at 13% of the global economy and more than £110bn of trade in 2019. ... With this in mind, the UK’s importance in the development of new chemical

  • Pharmaceutical social media after Cambridge Analytica Pharmaceutical social media after Cambridge Analytica

    The House of Commons has called for new independent regulation to be funded by a levy on tech companies operating in the UK, in order “.to create a regulatory system for ... prescription-only medicines is illegal outside the United States or New Zealand

  • The pill branding The pill branding

    and New Zealand.

  • Deal Watch table for July 2014 Deal Watch table for July 2014

    635. Zealand Pharma/ Boehringer Ingelheim. R&D collaboration. Peptide discovery collaboration with cardio-metabolic focus. ... 12. All deals are worldwide unless otherwise noted. Europe, Japan, Canada, Australia and New Zealand.

  • Pharma deals during July 2014 Pharma deals during July 2014

    prohibit Cosmo from competing directly with the new company in the gastrointestinal area in the US. ... In 2014, under this new agreement, Zealand expects to receive payments from its partner of around $7.5m.

More from intelligence
Approximately 0 fully matching, plus 7 partially matching documents found.

Latest appointments

  • Porterhouse announces members of medical advisory group Porterhouse announces members of medical advisory group

    She has a BSc and a MBChB gained from the University of Otago, New Zealand. ... After graduating, Sykes worked in hospitals in the Auckland region of New Zealand for three years across a range of medical specialities.

  • GSK appoints president of global pharmaceuticals GSK appoints president of global pharmaceuticals

    He also brings management experience from Sanofi's operations in the US, Thailand, New Zealand and Australia to the role. ... Luke will bring a strong new voice to the decisions and choices we will have to make for our pharmaceuticals business.

  • Dr Susanne Fiedler takes over as CEO of MSD Germany Dr Susanne Fiedler takes over as CEO of MSD Germany

    based role as managing director of MSD Australia and New Zealand. ... She will officially take on her new role on 1 February, when Quodt moves to a new European level position.

  • Zealand Pharma appoints new CEO Zealand Pharma appoints new CEO

    Britt Meelby Jensen joins from cancer diagnostics firm Dako. Denmark-based Zealand Pharma has appointed Britt Meelby Jensen as its new CEO, effective from January 15, 2015. ... Regarding his departure from the company, Solomon said: "Zealand is entering

  • PharmaVentures increases its Asia-Pacific presence PharmaVentures increases its Asia-Pacific presence

    Aki von Roy will be based in Auckland, New Zealand. Oxford, UK-headquartered advisory firm PharmaVentures has appointed Aki von Roy as an associate based in Auckland, New Zealand.

More from appointments
Approximately 0 fully matching, plus 14 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 1 fully matching, plus 17 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Say Communications

Influencing positive behaviours and delivering change is what drives us, using thought leadership, education, social and professional engagement and compelling,...

Latest intelligence

Our Top 5 Pharma Picks From Cannes Lions
Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....
The Evolving Role of the Sales Rep
The COVID-19 pandemic sparked an evolution in physician engagement. Jill Padgett, EdD, Head of Training, explores what this means for the sales force and shares her advice for succeeding in...
Measure your omnichannel maturity with our new tool
Try our Omnichannel Maturity Tool to gain tangible advice and an instant analysis of your omnichannel readiness....